Article info

Download PDFPDF
Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.

    Citation

    Mackie RM, Campbell I, Turbitt ML
    Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions.

    Publication history

    • First published April 1, 1984.
    Online issue publication 
    April 01, 1984

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.